Market Overview

Pfizer Rallies Off Allergan News

Related PFE
Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space
Jim Cramer Gives His Opinion On Tesla, Pfizer And UnitedHealth

Pfizer (NYSE: PFE) shares are trading higher by $0.88 at $31.60 in Tuesday's session. The Street is applauding a possible cancellation of its merger with Allergan (NYSE: AGN) due to the tax inversion news. Pfizer's last statement said it's conducting review of Department of Treasury's actions.

In a volatile session, the issue has found support just under Monday's close ($30.72), reaching $30.58 and rallying firmly into the $31 handle. It is now approaching its January 8 high of $31.63. There may be additional resistance at the pair of highs from January 6 ($31.90) and January 7 ($431.81).

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (AGN + PFE)

View Comments and Join the Discussion!